BofA: Bristol update may boost Cytokinetics shares
Go back to BofA: Bristol update may boost Cytokinetics shares| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.61 +1.56 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.80 | 52 Week Low | $49.03 | |||
| Day High | $68.64 | P/E | 43.90 | |||
| Day Low | $66.61 | EPS | $1.54 | |||
| Volume | 13,897,982 | |||||
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 77.74 +1.64 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.10 | 52 Week High | $13.18 | |||
| Open | $77.23 | 52 Week Low | $6.00 | |||
| Day High | $77.88 | P/E | N/A | |||
| Day Low | $76.17 | EPS | $-1.24 | |||
| Volume | 1,505,964 | |||||
